Who is sponsoring NCT04474977?

NCT04474977 is sponsored by Assiut University.

What drugs are being tested in NCT04474977?

Interventions in NCT04474977: Microvascular Decompressive Surgery.

What condition does NCT04474977 study?

NCT04474977 studies Hemifacial Spasm.

Is NCT04474977 still recruiting?

NCT04474977 is currently status unknown. Last updated 17 July 2020.

Last reviewed 2020-07-17 · How we verify

NCT04474977

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microvascular Decompressive Surgery for Hemifacial Spasm

Status unknown Last updated 17 July 2020

What this trial tests

trial testing Microvascular Decompressive Surgery in Hemifacial Spasm in 30 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 September 2022

1 March 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 September 2020
Primary completion	1 September 2022
Estimated completion	1 March 2023

Drugs / interventions tested

Microvascular Decompressive Surgery

Conditions studied

Hemifacial Spasm — all drugs for Hemifacial Spasm →

Sponsor

Assiut University

Who can join

Adults 20 to 60, any sex, with Hemifacial Spasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Review the clinical outcomes of Micro vascular decompression of Hemi facial Spasm. * Assess safety and efficacy of Micro vascular decompression. * Improve the outcome of these patients and decease rate of recurrence and complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04474977 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 17 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing